Oncology Central

GE Healthcare: Innovation to improve breast cancer diagnostics


Uncertain diagnoses usually call for additional imaging and you would refer your patient for a breast MRI, knowing its limitations.

What if you had an alternative that could help you give your patients a quick and confident diagnosis and free up your MRI for other procedures?

With SenoBright, you can give your patients a confident diagnosis the same day, in the same place, in less than 7 minutes after the inconclusive mammogram. It helps you to reduce false positives and helps prevent unnecessary biopsies and surgeries.

Clinicians have found SenoBright to be an effective alternative to MRI as a follow-up to ambiguous mammograms.

Read the entire customer story.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.